Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
West Afr J Med ; 39(9): 982-984, 2022 Sep 16.
Article in English | MEDLINE | ID: covidwho-2034207

ABSTRACT

This is a case of a 53-year-old African American woman with newly diagnosed concomitant acute cholecystitis, diverticulitis, and SARS-COV-2 infection. She underwent treatment for COVID-19 with antibiotics and supportive treatment, and on day 32 after initial symptoms presented, she had an elective laparoscopic cholecystectomy. Our patient was one of the first cases to present with acute cholecystitis and diverticulitis complicated by COVID-19, and serves as a template for surgical management of non-emergent abdominal pathologies in the midst of the COVID-19 pandemic.


Voici le cas d'une Afro-Américaine de 53 ans chez qui on a diagnostiqué récemment une cholécystite aiguë concomitante, une diverticulite et une infection par le SRAS-COV-2. Elle a été traitée pour l'infection COVID-19 avec des antibiotiques et un traitement de soutien, et le 32e jour après l'apparition des premiers symptômes, elle a subi une cholécystectomie laparoscopique élective. Notre patiente a été l'un des premiers cas à présenter une cholécystite et une diverticulite aiguës compliquées par le COVID-19, et sert de modèle pour la gestion chirurgicale des pathologies abdominales non urgentes au milieu de la pandémie de COVID-19. Mots-clés: COVID-19, Diverticulite, Cholécystite, SARCOV-2.


Subject(s)
COVID-19 , Cholecystitis, Acute , Diverticulitis, Colonic , Diverticulitis , Abscess/complications , Abscess/therapy , Anti-Bacterial Agents/therapeutic use , COVID-19/complications , Cholecystitis, Acute/complications , Cholecystitis, Acute/diagnosis , Cholecystitis, Acute/surgery , Diverticulitis/complications , Diverticulitis, Colonic/complications , Diverticulitis, Colonic/surgery , Female , Humans , Middle Aged , Pandemics , Retrospective Studies , SARS-CoV-2 , Treatment Outcome
2.
Vestn Otorinolaringol ; 87(2): 70-75, 2022.
Article in Russian | MEDLINE | ID: covidwho-1863439

ABSTRACT

The pandemic of the new coronavirus infection (COVID-19) has identified new diagnostic and medical tasks before different doctors. As observations show, children have the flow of infection easier than adults. However, in some cases, COVID-19 in children proceeds extremely difficult, with fever and multisystem inflammation, possibly requiring treatment in the resuscitation department. In domestic practice, the term "Multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19" is used to indicate the disease. Among the local symptoms of MIS are inflammations of the skin and mucous membranes, as well as various lymphadenopathy. The article presents the results of our clinic's observation of 205 patients with MIS for the period from May 2020 to May 2021. In some patients, the clinical manifestations of MIS-C required differential diagnosis with parapharyngeal abscesses (PPA). For this purpose, the children were consulted by an otorhinolaryngologist and a CT scan of the neck with contrast enhancement was performed. Despite the striking clinical manifestations similar to PPA, in no case was a pharyngeal abscess revealed. Both of these diseases are potentially fatal if treatment is not started on time, and therefore we believe that the awareness of otorhinolaryngologists about the manifestations of MIS-C will be useful in modern clinical practice.


Subject(s)
COVID-19 , Pharyngeal Diseases , Abscess/diagnosis , Abscess/etiology , Abscess/therapy , Adult , COVID-19/complications , COVID-19/diagnosis , Child , Diagnosis, Differential , Humans , Pharyngeal Diseases/diagnosis , SARS-CoV-2 , Systemic Inflammatory Response Syndrome
3.
Am J Case Rep ; 23: e936034, 2022 May 12.
Article in English | MEDLINE | ID: covidwho-1841694

ABSTRACT

BACKGROUND COVID-19 is treated using antiviral and immunosuppressive drugs. Therefore, patients treated for COVID-19 may have an increased risk of secondary infection and a masked inflammatory response. We present a case of a deep neck abscess caused by pyogenic sternoclavicular arthritis during treatment for COVID-19. CASE REPORT A 55-year-old man with COVID-19 was admitted to the hospital with hypoxemia. He was then treated with remdesivir, tocilizumab, and dexamethasone and was placed in the prone position. When his condition stabilized, pain in the left shoulder appeared. There was no fever or elevation in inflammation markers, and he was administered analgesics. However, the pain worsened and redness of the left neck appeared. Plain computed tomography (CT) showed swelling of the left neck muscles. Because cellulitis was suspected, he was treated with antibiotics, but his symptoms did not improve. Three days after the plain CT, contrast-enhanced CT showed sternoclavicular arthritis, deep neck abscess, and mediastinal abscess. Therefore, an emergency incisional drainage was performed under general anesthesia. Wound cleaning and drainage were continued after surgery, and after drainage tubes were removed, the patient was discharged on postoperative day 17. CONCLUSIONS Cervical infections after COVID-19 treatment have been reported in a few cases. Particularly, deep neck abscesses require more attention since they could be fatal if not treated immediately. If a secondary infection is suspected in a patient treated with immunosuppressive drugs for COVID-19, a thorough physical examination should be performed to avoid misdiagnosis.


Subject(s)
Arthritis, Infectious , COVID-19 Drug Treatment , Coinfection , Abscess/diagnosis , Abscess/etiology , Abscess/therapy , Arthritis, Infectious/therapy , Drainage , Humans , Male , Middle Aged , Pain
4.
Surgeon ; 19(5): e270-e275, 2021 Oct.
Article in English | MEDLINE | ID: covidwho-1117692

ABSTRACT

BACKGROUND: During the coronavirus pandemic, paediatric patients will still likely present with dental pain and infection. In order to streamline care at King's College Hospital (KCH), Paediatric Dentistry and Oral and Maxillofacial Surgery (OMFS) have developed a collaborative working approach allowing patients to be treated effectively and to streamline patient care in the absence of easy access to general anaesthetic facilities. METHOD: Presenting complaints, treatment need and the treatment received were recorded for all paediatric patients presenting with dental pain and infection in the "lockdown" period (23rd March- 14th June) during "normal" working hours and "out of hours" to either paediatric dentistry or OMFS. RESULTS: 420 calls were triaged which converted to 67 patients seen face-to-face for oro-facial pain and infection. 41% of children were treated successfully under Local anaesthetic alone, only 13% required a general anaesthetic (GA) in the "lockdown" period. The vast majority of patients had antibiotics prescribed prior to attendance (80%). CONCLUSION: We have demonstrated the demographic, presenting complaints and treatment need of patients who presented to KCH during the lockdown period with dental pain and infection. The majority were able to be treated without needing for GA facilities. This paper highlights how a collaborative approach between paediatric dentistry and OMFS can help streamline patient care and is a model which can be adopted by other units in the event of further "lockdowns".


Subject(s)
Abscess/epidemiology , COVID-19/epidemiology , Communicable Disease Control , Facial Pain/epidemiology , Abscess/diagnosis , Abscess/therapy , Adolescent , COVID-19/prevention & control , Child , Child, Preschool , Facial Pain/diagnosis , Facial Pain/therapy , Female , Humans , Male , Mouth Diseases/diagnosis , Mouth Diseases/epidemiology , Mouth Diseases/therapy , Pulpitis/diagnosis , Pulpitis/epidemiology , Pulpitis/therapy , Retrospective Studies , United Kingdom
6.
Urology ; 142: 26-28, 2020 08.
Article in English | MEDLINE | ID: covidwho-116352

ABSTRACT

OBJECTIVE: To provide guidance when performing bedside urologic procedures on severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) positive patients and offer considerations to maximize the safety of the patients and providers, conserve supplies, and provide optimal management of urologic issues. METHODS: Urologic trainees and attending physicians at our institution, who are familiar with existing safety recommendations and guidelines regarding the care of infected patients, were queried regarding their experiences to determine an expert consensus on best practices for bedside procedures for SARS-CoV-2 positive patients. RESULTS: Our team developed the following general recommendations for urologic interventions on SARS-CoV-2 positive patients: maximize use of telehealth (even for inpatient consults), minimize in-room time, use personal protective equipment appropriately, enlist a colleague to assist, and acquire all supplies that may be needed and maintain them outside the room. Detailed recommendations were also developed for difficult urethral catheterization, bedside cystoscopy, incision and drainage of abscesses, and gross hematuria/clot irrigations. CONCLUSION: As patients hospitalized with SARS-CoV-2 infection are predominantly men over 50 years old, there are significant urologic challenges common in this population that have emerged with this pandemic. While there is tremendous variation in how different regions have been affected, the demographics of SARS-CoV-2 mean that urologists will continue to have a unique role in helping to manage these patients. Here, we summarize recommendations for bedside urologic interventions specific to SARS-CoV-2 positive patients based on experiences from a large metropolitan hospital system. Regulations and requirements may differ on an institutional basis, so these guidelines are intended to augment specific local protocols.


Subject(s)
Betacoronavirus , Coronavirus Infections/epidemiology , Diagnostic Techniques, Urological , Pneumonia, Viral/epidemiology , Point-of-Care Systems/organization & administration , Urologic Diseases/therapy , Urology Department, Hospital , Abscess/therapy , COVID-19 , Cystoscopy/methods , Drainage , Hematuria/therapy , Humans , Infection Control , Pandemics , Personal Protective Equipment , SARS-CoV-2 , Telemedicine , Therapeutic Irrigation/methods , Urinary Catheterization/methods
SELECTION OF CITATIONS
SEARCH DETAIL